IET Nanobiotechnology

IET Nanobiotechnology is a peer-reviewed journal publishing original research and review articles on nanobiotechnology at the micro and nanoscale. It is owned by the Institution of Engineering and Technology (IET) of the United Kingdom and published in partnership with Wiley as a gold open access journal. The title dates from 2007, when IEE Proceedings - Nanobiotechnology was renamed, and its 2025 Journal Impact Factor is 4.8.《IET 纳米生物技术》（IET Nanobiotechnology）是英国工程技术学会（IET）拥有、与 Wiley 合作出版的同行评审期刊，以金色开放获取方式刊发微纳尺度纳米生物技术领域的原创论文与综述。该刊 2007 年由《IEE 纳米生物技术学报》更名而来，2025 年期刊影响因子为 4.8。

Scope

• It is a dedicated forum for high-quality original and comprehensive research advancing microscale and nanoscale science and engineering for biological and biomedical applications.该刊是专门发表高质量原创与综合性研究的园地，致力于推动面向生物与生物医学应用的微米与纳米尺度科学与工程。
• It covers applications of nanobiomaterials for theranostics, uniting therapy and diagnostics on single nanoscale platforms.收录纳米生物材料在诊疗一体化中的应用，即将治疗与诊断融于同一纳米平台的研究。
• Nanophotonic technologies, including surface-enhanced Raman scattering for bioanalysis, form a central area of the journal.纳米光子技术（包括用于生物分析的表面增强拉曼散射）是该刊的核心领域之一。
• Nanobiosensing technologies for nanomedicine and nanoprobes for biological imaging techniques are actively solicited.面向纳米医学的纳米生物传感技术以及用于生物成像的纳米探针是该刊积极邀稿的方向。
• Micro- and nanofluidic systems and lab-on-a-chip technologies applied to pharmaceutical, biomedical and biotechnological problems fall within its scope.应用于制药、生物医学与生物技术问题的微纳流体系统与芯片实验室技术属于其收录范围。
• Nanomachining and nanofabrication techniques directed at biomedical applications, including scanning probe and atomic force microscopy methods, are covered.收录面向生物医学应用的纳米加工与纳米制造技术，包括扫描探针与原子力显微镜相关方法。
• Colloid chemistry applied to nanobiotechnology, for example bioactive nanoparticles, remains a traditional strength of the journal.应用于纳米生物技术的胶体化学（如生物活性纳米颗粒）仍是该刊的传统优势方向。
• Environmental health and safety issues, nanotoxicology, and the risks of nanomaterials to human health and the environment are within scope.环境健康与安全、纳米毒性以及纳米材料对人类健康与环境的潜在风险均在收录范围之内。
• The journal also welcomes artificial intelligence and machine learning approaches applied to nanobiotechnology research.该刊还欢迎应用于纳米生物技术研究的人工智能与机器学习方法。

History

• The journal began in 2003 as IEE Proceedings - Nanobiotechnology (ISSN 1478-1581), a new title in the IEE Proceedings family, and its founding editorial was written by Jon Cooper and John Ryan.该刊前身为 2003 年创刊的《IEE 纳米生物技术学报》（ISSN 1478-1581），属 IEE Proceedings 系列新刊，创刊号社论由 Jon Cooper 与 John Ryan 撰写。^[1]
• In 2006 the Institution of Electrical Engineers merged with the Institution of Incorporated Engineers to form the Institution of Engineering and Technology, and the journal was retitled IET Nanobiotechnology from 2007 under new ISSNs 1751-8741 (print) and 1751-875X (online).2006 年，英国电气工程师学会与工业企业工程师学会合并组建英国工程技术学会，该刊随之于 2007 年更名为《IET 纳米生物技术》，并启用新书号 1751-8741（纸本）与 1751-875X（在线）。
• In 2013 the IET entered a partnership with Wiley, and the journal has been hosted on the Wiley Online Library since volume 7 of that year.2013 年，IET 与 Wiley 达成合作，该刊自当年第 7 卷起迁至 Wiley Online Library 平台出版。
• The journal became fully open access in 2021, publishing all articles under the CC BY license with an article publication charge.该刊于 2021 年转为完全开放获取，全部论文以 CC BY 许可发布并收取文章处理费。
• Since 2024 the journal has used the publication year as its volume number and releases articles online continuously.自 2024 年起，该刊卷号改用出版年份标示，论文在线连续发布。
• Its Journal Impact Factor has risen sharply in recent years, from 1.847 in 2021 and 2.05 in 2022 to 4.9 in 2024 and 4.8 in 2025, placing it in Q1 of the SCIE category Biochemical Research Methods.其期刊影响因子近年快速攀升，从 2021 年的 1.847 与 2022 年的 2.05 升至 2024 年的 4.9 与 2025 年的 4.8，在 SCIE 生化研究方法（Biochemical Research Methods）类居 Q1 区。
• More than 1,100 articles carrying digital object identifiers have appeared under the current title, and the archive is preserved in the CLOCKSS, PubMed Central and Portico services.现名下已发表 1,100 余篇注册数字对象标识符的论文，过刊典藏于 CLOCKSS、PubMed Central 与 Portico 三大数字存档服务。

Editors

• The editor-in-chief is Duo Lin, professor at Fujian Normal University in China and deputy director of the Ministry of Education Key Laboratory of Optoelectronic Science and Technology for Medicine, whose work centres on Raman spectroscopy and biomedical sensing.现任主编为林多（Duo Lin），福建师范大学教授、医学光电科学与技术教育部重点实验室副主任，研究方向聚焦拉曼光谱与生物医学传感。
• Ronald Pethig of the University of Edinburgh, a pioneer of bioelectronics and dielectrophoresis, served as editor-in-chief in earlier years.爱丁堡大学的 Ronald Pethig 曾任该刊主编，其在生物电子学与介电电泳领域享有开创者声誉。
• The board lists more than twenty academic editors drawn from China, India, the Republic of Korea, Japan, the United Kingdom, the United States, Egypt, Pakistan and Iran.编委会列有学术编辑二十余位，来自中国、印度、韩国、日本、英国、美国、埃及、巴基斯坦与伊朗等国。
• Manuscripts are submitted through Wiley's Research Exchange platform, pre-screened by the editorial office, and assessed by at least two anonymous external reviewers under a single-anonymized peer review model.稿件经 Wiley 的 Research Exchange 平台投稿，由编辑部预审，并在单盲同行评审模式下由至少两位匿名外审专家评审。
• Submissions whose topics fall outside the journal's scope are frequently rejected without refereeing, and replication studies are explicitly encouraged.主题超出该刊范围的稿件常在未经外审时即被退稿，该刊明确鼓励重复验证性研究。
• The journal charges an article publication charge of 2,600 US dollars, with a 15 percent discount for IET members and waivers for corresponding authors from eligible countries.该刊收取 2,600 美元的文章处理费，IET 会员投稿可享 15% 折扣，符合条件国家的通讯作者可申请费用减免。
• It is indexed in the Science Citation Index Expanded, Scopus, MEDLINE, Embase, Inspec, Compendex and the Directory of Open Access Journals.该刊被科学引文索引扩展版（SCIE）、Scopus、MEDLINE、Embase、Inspec、Compendex 与开放获取期刊目录（DOAJ）收录。